The identification of HIV ultimately led to the development of therapies that specifically target the virus’ ability to make new copies of itself. These therapies have radically altered the lives of ...
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study In the Thabatse Cancer Cohort, ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Brentuximab ...
Bisphosphonate Combination Therapy in the Management of Postchemotherapy Avascular Necrosis of the Femoral Head in Adolescents and Young Adults: A Retrospective Study From India There are only limited ...
Q: Could you tell me about the causes, treatment and remission rates for Burkitt lymphoma? A: Burkitt lymphoma is a highly aggressive, rapidly growing type of B cell lymphoma. It’s caused by an ...
Human immunodeficiency virus (HIV) infection attackes the immune system of infected persons. It can be spread through unprotected sex, shared needles and other drug paraphernalia, and from mother to ...
Please provide your email address to receive an email when new articles are posted on . HIV status did not affect outcomes after first-line chemotherapy for patients with advanced classical Hodgkin ...
Non-Hodgkin's lymphoma is a group of cancers that start in lymphocytes -- your immune system’s infection-fighting white blood cells. Doctors divide it into types based on the kind of lymphocyte each ...
Lymphoma is a type of cancer that begins in lymphocytes — the white blood cells that play a vital role in the immune system. These cells are located in areas such as the lymph nodes, spleen, thymus, ...